Lifevantage (LFVN) reported Q2 EPS of ($0.07), $0.12 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $53.7 million versus the consensus estimate of $51.17 million.
Lifevantage (LFVN) reported Q2 EPS of ($0.07), $0.12 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $53.7 million versus the consensus estimate of $51.17 million.